Cryo Cell International (CCEL) Shares Outstanding (Weighted Average) (2010 - 2026)

Cryo Cell International (CCEL) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $8.1 million in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $8.1 million, changed 0.33% year-over-year; the trailing twelve-month figure through Feb 2026 was $8.1 million (changed 0.33% YoY), and the FY2025 annual result was $8.1 million, down 0.76% from the prior year.
• Shares Outstanding (Weighted Average) was little changed at $8.1 million in Q1 2026 per CCEL's latest filing, from $8.1 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $8.5 million in Q1 2022 and troughed at $8.1 million in Q1 2026.
• A 5-year average of $8.3 million and a median of $8.3 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Weighted Average) advanced 12.63% in 2022, then declined 2.71% in 2024.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $8.5 million in 2022, then decreased by 1.47% to $8.3 million in 2023, then slipped by 2.52% to $8.1 million in 2024, then retreated by 0.76% to $8.1 million in 2025, then dropped by 0.17% to $8.1 million in 2026.
• Business Quant data shows CCEL's Shares Outstanding (Weighted Average) at $8.1 million in Q1 2026, $8.1 million in Q4 2025, and $8.1 million in Q3 2025.